Page 151 - Assurance of Sterility for Sensitive Combination Products and Materials

Package/container closures 133

laws of the Member States relating to active implantable medical devices (90/385/
EEC) as amended by Council Directive 93/42/EEC of 14 June 1993, Council Direc-
tive 93/68/EEC of 22 July 1993, Regulation (EC) No 1882/2003 of the European
Parliament and of the Council of 29 September 2003 and by Directive 2007/47/EC
of the European Parliament and of the Council of 5 September 2007 (consolidated
version). OJ, 1990. L 189.
[80] Council and European Parliament, DIRECTIVE 2001/83/EC OF THE EURO-
PEAN PARLIAMENT AND OF THE COUNCIL of 6 November 2001 on the
Community code relating to medicinal products for human use. OJ, 2001. L 311,
28.11. 2001, p. 67.
[81] ASTM International, F1980—16 Standard Guide for Accelerated Aging of Sterile
Barrier Systems for Medical Devices, 2016. West Conshohocken, PA 19428-2959,
United States.
[82] U.S. Food & Drug Administration (FDA), 21 CFR-Chapter I-Subchapter C-Part 211—
Current Good Manufacturing Practice for Finished Pharmaceuticals, in 21. 2016.
[83] International Council for Harmonisation (ICH), ICH Quality Guidelines, http://
www.ich.org/products/guidelines/quality/article/quality-guidelines.html.
[84] International Council for Harmonisation (ICH), ICH Harmonised Tripartite Guide-
line—Stability Testing of New Drug Substances and Products Q1A(R2). 2003.
[85] Global Harmonization Task Force, GHTF-SG3—Quality Management Systems—
Process Validation Guidance. 2004.
[86] U.S. Food & Drug Administration (FDA), Guidance for Industry—Process Validation:
General Principles and Practices (http://www.fda.gov/downloads/Drugs/Guidance-
ComplianceRegulatoryInformation/Guidances/UCM070336.pdf), Center for Drug
Evaluation and Research (CDER), Center for Biologics Evaluation and Research
(CBER), and Center for Veterinary Medicine (CVM), Editors. 2011.
[87] Notified Body Operations Group (NBOG), ed, NBOG BPG 2014-3—Guidance for
Manufacturers and Notified Bodies on Reporting of Design Changes and Changes
of the Quality System, European Association for Medical Devices of Notified Bodies,
Brussels, 2014.
[88] T. Wagner, M.H. Scholla, Sterile barrier systems: managing changes and revalida-
tions, http://www.ivtnetwork.com/article/sterile-barrier-systems-managing-chang-
es-and-revalidations. J. Validation Technol. 19 (3) (2013).
[89] N. Kaller, Medical Packaging Study—Reducing the Risk of Failure through Perfor-
mance Testing of Packaging Made from Various Materials, Medical Packaging Com-
munity, DuPont, 2014, p. 22.
[90] Sterile Barrier Association, Sample Validation Flow Diagram, [cited 2017 6 July 2017];
Available from: http://www.sterilebarrier.org/medical-device-manufacturers/valida-
tion-process/sample-validation-flow-diagram/, 2017.
[91] D.S. Moore, W.I. Notz, M.A. Fligner, The Basic Practice of Statistics, Macmillan
Learning, 2015.
[92] J. Stein, N. Doganaksoy, Sample size considerations for assessing the equivalence of
two process means, Qual. Eng. 12 (1) (1999) 105–110.
[93] D.J. Schuirmann, A comparison of the two one-sided tests procedure and the power
approach for assessing the equivalence of average bioavailability, J. Pharmacokinet.
Biopharm. 15 (6) (1987) 657–680.
[94] L.S. Nelson, Nomograph of sample size for estimating standard deviation, J. Qual.
Technol. 8 (3) (1976) 179–180.
[95] D.C. Montgomery, Introduction to Statistical Quality Control, J. Wiley & Sons, 2013.
[96] E. Sternberger-Rutzel, Drinking Medicines with a Straw Instead of Swallowing ‘bit-
ter’ Pills, 2014.
[97] J. Cui, et al., Synthesis of High Performance Cyclic Olefin Polymers (COPS) with